NCT06694337View on ClinicalTrials.gov

Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain)

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

June 15, 2025

Study Completion Date

June 23, 2025

Conditions

Low Back Pain

Interventions

DIETARY_SUPPLEMENT

300 mg Palmitoylethanolamide (PEA) Phytosome®

Oral supplement intake

DIETARY_SUPPLEMENT

450 mg Palmitoylethanolamide (PEA) Phytosome®

Oral supplement intake

OTHER

Control group

Placebo

Trial Locations (1)

Unknown

Lady Reading Hospital, Peshawar

All Listed Sponsors

lead

Liaquat University of Medical & Health Sciences

OTHER

NCT06694337 - Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain) | Biotech Hunter | Biotech Hunter